Assessment of Response to the Conventional Periodontal Treatment Based on the Blood Group Phenotypes.
- Conditions
- Chronic Periodontitis
- Registration Number
- NCT03644901
- Lead Sponsor
- Damascus University
- Brief Summary
The aim of this study is to find out if one blood group phenotype is more responsive than the others to the nonsurgical periodontal treatment.
- Detailed Description
To the best of our knowledge, this is the first (research) randomized clinical trial that assesses how patient respond to the nonsurgical periodontal treatment based on their blood group phenotype.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- systematically healthy.
- have at least 20 teeth excluding the third molars.
- had not received any periodontal treatment or antibiotic therapy for dental or medical reason 6 month prior to the study.
- diagnosed with generalized chronic periodontitis (>30% of the sites have probing depth ≥4), and a minimum of six teeth with probing depth of 5-6 mm.
- smokers and alcoholics.
- pregnancy.
- history of a systematic disease such as diabetes, leukemia, epilepsy.
- participants who are unable to perform routine oral hygiene.
- use of orthodontic appliances.
- participants who are unable to perform routine oral hygiene.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in relative attachment level. measures will be taken at baseline and after two months from treatment. the relative attachment level measures the length form the base of the periodontal pocket to a stent
- Secondary Outcome Measures
Name Time Method Change in plaque Index index will be taken at baseline and after two months from treatment. it is used to designate the level of plaque accumulation.
Change in periodontal probing depth. measures will be taken at baseline and after two months from treatment. the distance between the gingival margin to the base of the periodontal pocket.
Change in gingival index index will be taken at baseline and after two months from treatment. it is used to designate the level of the gingival inflammation.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Department of Periodontics
🇸🇾Damascus, Syrian Arab Republic
Department of Periodontics🇸🇾Damascus, Syrian Arab Republic